Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment

H Zhao, J Zhang, X Cheng, X Nie, B He - Journal of Ovarian Research, 2023 - Springer
Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by
chronic ovulation dysfunction and overabundance of androgens; it affects 6–20% of women …

Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications

Y Sun, S Gao, C Ye, W Zhao - Frontiers in cellular and infection …, 2023 - frontiersin.org
Polycystic ovary syndrome (PCOS) is the most common endocrine diseases in women of
childbearing age that leads to menstrual disorders and infertility. The pathogenesis of PCOS …

[HTML][HTML] Metabolic syndrome

S Swarup, A Goyal, Y Grigorova, R Zeltser - StatPearls [internet], 2022 - ncbi.nlm.nih.gov
Objectives: Review the causes of metabolic syndrome. Describe the evaluation of a patient
with metabolic syndrome. Summarize the treatment of metabolic syndrome. Outline the …

The challenges of obesity for fertility: A FIGO literature review

D Gautam, N Purandare, CV Maxwell… - … of Gynecology & …, 2023 - Wiley Online Library
Obesity has been linked to infertility through several mechanisms, including at a molecular
level. Those living with obesity face additional barriers to accessing fertility treatments and …

[HTML][HTML] Prevalence and etiology of eating disorders in polycystic ovary syndrome: a scoping review

S Lalonde-Bester, M Malik, R Masoumi, K Ng… - Advances in …, 2024 - Elsevier
Polycystic ovary syndrome (PCOS) is the most common endocrine-metabolic disorder
affecting females across the lifespan. Eating disorders (EDs) are psychiatric conditions that …

Usage of glucagon-like peptide-1 for obesity in children; updated review of Clinicaltrials. gov

NM Alorfi, FS Alshehri - Journal of Multidisciplinary Healthcare, 2023 - Taylor & Francis
Background Obesity in both adults and children is a primary health concern that can lead to
many complications at a young age, including insulin resistance, type 2 diabetes, and other …

Association between pre-pregnancy overweightness/obesity and pregnancy outcomes in women with polycystic ovary syndrome: a systematic review and meta …

ST Yang, CH Liu, SH Ma, WH Chang, YJ Chen… - International journal of …, 2022 - mdpi.com
Polycystic ovary syndrome (PCOS) is a common metabolic problem in women of
reproductive age. Evidence suggests pregnant women with PCOS may have a higher risk of …

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome

C Xing, H Zhao, J Zhang, B He - Frontiers in endocrinology, 2022 - frontiersin.org
Objective To observe the effect of metformin (MET) monotherapy versus MET plus liraglutide
(LIRA) on gonadal and metabolic profiles in overweight patients with polycystic ovary …

Therapeutic potential of glucagon-like peptide-1 agonists in polycystic ovary syndrome: from current clinical evidence to future perspectives

M Jensterle, R Herman, A Janež - Biomedicines, 2022 - mdpi.com
Despite the continuous effort to understand the pathophysiology and determine potential
therapeutic targets, PCOS treatment largely depends on lifestyle intervention and …

[HTML][HTML] GLP-1 receptor agonists, polycystic ovary syndrome and reproductive dysfunction: Current research and future horizons

GS Papaetis, A Kyriacou - Advances in Clinical and …, 2022 - advances.umw.edu.pl
Polycystic ovary syndrome (PCOS) is a disorder that involves several organ systems and
cellular pathways. It is strongly influenced by environmental and epigenetic factors. The …